| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/12/2011 | US7977079 Nucleic acid constructs encoding cytotoxic ribonuclease variants |
| 07/12/2011 | US7977077 Synthesis of intermediates of oseltamivir carboxylates |
| 07/12/2011 | US7977073 Polynucleotide encoding a thermostable amide hydrolase and methods for producing an L-α-amino acid |
| 07/12/2011 | US7977071 Binding moieties based on shark ignar domains |
| 07/12/2011 | US7977069 DNA encoding a CCK-8S G-protein coupled receptor, and vectors, transformants, cell kits, and methods employing such DNA |
| 07/12/2011 | US7977068 Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries |
| 07/12/2011 | US7977065 Yeast strains autonomously producing steroids |
| 07/12/2011 | US7977060 Mammalian sweet taste receptors |
| 07/12/2011 | US7977059 17867, a novel human aminopeptidase |
| 07/12/2011 | US7977053 Circular probe amplification (CPA) using energy-transfer primers |
| 07/12/2011 | US7977049 Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms |
| 07/12/2011 | US7977048 Using immobilized immunoglobulins and fluorescent resonance energy transfer as tools in detection viral particles in bodily fluids |
| 07/12/2011 | US7977047 Delete sequence in M. tuberculosis, method for detecting mycobacteria using these sequences and vaccines |
| 07/12/2011 | US7977046 Method of selecting DNA constructs for herbicide tolerance in plants |
| 07/12/2011 | US7976849 Hepatitis-C virus testing |
| 07/12/2011 | US7976848 Optimized expression of HPV 58 L1 in yeast |
| 07/12/2011 | US7976846 Stress protein complex; a grp170 polypeptide and an immunogenic polypeptide; antitumor |
| 07/12/2011 | US7976845 Viral protein for use as tool in developing vaccines for prevention and treatment of viral infection |
| 07/12/2011 | US7976844 Fusion proteins of Mycobacterium tuberculosis |
| 07/12/2011 | US7976840 Use of anti-GL50 antibodies for the downmodulation of an immune response |
| 07/12/2011 | US7976836 Treatment of stroke using placental stem cells |
| 07/12/2011 | US7976743 drug deliverying nitric oxide containing liposomes for hyperplasia, atherosclerosis; drug conjugated with antibody for drug target at specific cells; delivery rosiglitazone; reduce side effect; freezing under pressure |
| 07/12/2011 | CA2604398C Method and kit for expressing protein under regulation of the expression from repeated sequence formed by gene amplification and transformant |
| 07/12/2011 | CA2562738C Soluble rubella e1 envelope antigens |
| 07/12/2011 | CA2506318C Unexpected surface proteins in neisseria meningitidis |
| 07/12/2011 | CA2486738C Method for identifying immunoreactive peptides |
| 07/12/2011 | CA2470711C Novel n-acetylglucosamine transferase, nucleic acid encoding the same, antibody against the same and use thereof for diagnosing cancer or tumor |
| 07/12/2011 | CA2468957C Methods of propagation of influenza virus in cell lines over expressing sialyl transferases |
| 07/12/2011 | CA2463616C Affinity enhancement agents |
| 07/12/2011 | CA2461443C Nucleic acid and amino acid sequences encoding high-level expressor factor viii polypeptides and methods of use |
| 07/12/2011 | CA2457528C Rna interference mediated inhibition of hepatitis c virus (hcv) gene expression using short interfering nucleic acid (sina) |
| 07/12/2011 | CA2448947C Pseudotyping vih-1 vectors with the aid of rhabdovirus envelopes |
| 07/12/2011 | CA2446776C Self-containing lactococcus strain |
| 07/12/2011 | CA2440195C Synthetic genes and bacterial plasmids devoid of cpg |
| 07/12/2011 | CA2423052C Screening assays for agonists or antagonists of receptor activator of nf-kb |
| 07/12/2011 | CA2419148C Rabies virus-specific neutralizing human monoclonal antibodies and nucleic acids and related methods |
| 07/12/2011 | CA2415348C Isolated polynucleotide sequences encoding a fertility associated antigen |
| 07/12/2011 | CA2408851C Methods for refolding proteins containing free cysteine residues |
| 07/12/2011 | CA2405438C Hepatitis b core antigen fusion proteins |
| 07/12/2011 | CA2397347C Factor vii or viia-like molecules |
| 07/12/2011 | CA2393200C Methods for targeting cells that express fibroblast growth receptor-3 or-2 |
| 07/12/2011 | CA2389314C Methods and apparatus for the electronic, homogeneous assembly and fabrication of devices |
| 07/12/2011 | CA2362527C A novel, prostate-specific gene for diagnosis, prognosis and management of prostate cancer |
| 07/12/2011 | CA2352286C Intracellular targeted delivery of compounds by 70 kd heat shock protein |
| 07/12/2011 | CA2344599C Selective polymerase chain reaction of dna of which base sequence is completely unknown |
| 07/12/2011 | CA2341336C Elongase genes and uses thereof |
| 07/12/2011 | CA2340925C Transgenic amorpha-4,11-diene synthesis |
| 07/12/2011 | CA2329133C Recombinant venezuelan equine encephalitis virus vaccine |
| 07/12/2011 | CA2328593C Chemically assembled nano-scale devices |
| 07/12/2011 | CA2325058C Mammalian tolloid-like gene and protein |
| 07/12/2011 | CA2312274C Isolated dna encoding human h3 histamine receptor |
| 07/12/2011 | CA2302874C Jnk3 modulators and methods of use |
| 07/12/2011 | CA2291514C Methods for evaluating tissue morphogenesis and activity |
| 07/12/2011 | CA2277850C Genetic alterations associated with cancer |
| 07/12/2011 | CA2256758C Method of producing l-serine by fermentation |
| 07/12/2011 | CA2220442C Chromatin regulator genes |
| 07/12/2011 | CA2173329C Amylase variants |
| 07/12/2011 | CA2162555C Method for the culture in vitro of different stages of tissue parasites |
| 07/12/2011 | CA2162262C Methods for treating muscle diseases and disorders |
| 07/07/2011 | WO2011082422A2 Human immunodeficiency virus (hiv-1) highly conserved and low variant sequences as targets for vaccine and diagnostic applications |
| 07/07/2011 | WO2011082415A2 Methods, compositions, and kits for recovery of nucleic acids or proteins from fixed tissue samples |
| 07/07/2011 | WO2011082409A2 Treatment of interferon regulatory factor 8 (irf8) related diseases by inhibition of natural antisense transcript to irf8 |
| 07/07/2011 | WO2011082381A2 Plasmids and methods for peptide display and affinity-selection on virus-like particles of rna bacteriophages |
| 07/07/2011 | WO2011082325A2 Sequences of e.coli 055:h7 genome |
| 07/07/2011 | WO2011082318A2 Methods and compositions for the introduction and regulated expression of genes in plants |
| 07/07/2011 | WO2011082310A2 Methods and compositions for targeted polynucleotide modification |
| 07/07/2011 | WO2011082304A1 Engineering plant resistance to diseases caused by pathogens |
| 07/07/2011 | WO2011082217A2 Compositions and methods for the control of root lesion nematode |
| 07/07/2011 | WO2011082198A2 Cancer biomarkers to predict recurrence and metastatic potential |
| 07/07/2011 | WO2011082189A1 Production of hemagglutinin-neuraminidase protein in microalgae |
| 07/07/2011 | WO2011082107A1 Direct and continuous root alone or root/shoot production from transgenic events derived from green regenerative tissues and its applications |
| 07/07/2011 | WO2011082038A2 Improved reprogramming compositions |
| 07/07/2011 | WO2011081928A2 Compositions and methods for altering cocaine esterase activity |
| 07/07/2011 | WO2011081869A2 Method and materials for separating nucleic acid materials |
| 07/07/2011 | WO2011081502A2 Molecular marker related to ms k (nuclear-genetic male sterility gene) and certification method using same |
| 07/07/2011 | WO2011081501A2 Molecular marker for discrimination of ms3 (nuclear-genetic male sterility gene) and certification method using same |
| 07/07/2011 | WO2011081421A2 Complement c9 as markers for the diagnosis of cancer |
| 07/07/2011 | WO2011081415A2 Sirna for inhibiting c-met expression and an anti-cancer composition comprising the same |
| 07/07/2011 | WO2011081343A2 Transgenic pig in which ho-1 genes and tnfr1-fc genes are simultaneously expressed, and method for producing same |
| 07/07/2011 | WO2011081294A2 Recombinant adenovirus having anti-angiogenesis activity |
| 07/07/2011 | WO2011081238A1 Method and kit for predicting the reaction to treatment with vascular endothelial growth factor-specific tyrosine kinase inhibitor |
| 07/07/2011 | WO2011081189A1 Anti-iga1 antibody |
| 07/07/2011 | WO2011081171A1 Screening method |
| 07/07/2011 | WO2011081164A1 Anti-cd27 antibody |
| 07/07/2011 | WO2011081135A1 Phosphatidate phosphatase gene and use thereof |
| 07/07/2011 | WO2011081039A1 Marker for determining susceptibility to age-related macular degeneration, determination method, and determination kit |
| 07/07/2011 | WO2011081012A1 Detection method for microarray |
| 07/07/2011 | WO2011080796A1 Anti-cdh3 antibodies and uses thereof |
| 07/07/2011 | WO2011080329A2 Gpav gene resistant to nematodes in the nightshade family |
| 07/07/2011 | WO2011080301A2 Strains and method for the production of methionine |
| 07/07/2011 | WO2011080160A1 Improvements to nucleic acid elution |
| 07/07/2011 | WO2011080078A2 Thermostable xylanase for the selective hydrolysis of pentose-containing polysaccharides |
| 07/07/2011 | WO2011079668A1 Group of mutant ptpαgenes in malignant tumor and producing method thereof |
| 07/07/2011 | WO2011079445A1 Molecular markers for rice brown planthopper resistance gene and their application |
| 07/07/2011 | WO2011079431A1 Fusion protein with telomerase inhibiting activity, preparation method and use thereof |
| 07/07/2011 | WO2011079388A1 Modified yeast strains exhibiting enhanced fermentation of lignocellulosic hydrolysates |
| 07/07/2011 | WO2011079361A1 Modified bacterial strain and use thereof |
| 07/07/2011 | WO2011079356A1 Carbon nanotube conjugate for inhibiting pathogenic infection structures in plants |
| 07/07/2011 | WO2011059332A3 Improved immunomodulation by probiotics |
| 07/07/2011 | WO2011056911A9 Compositions and methods for enhancing production of a biological product |